David H. Raulet is an immunologist who specializes in studying the role of natural killer cells. He is a professor in the Department of Molecular and Cell Biology at the University of California, Berkeley where he also holds the Esther and Wendy Schekman Chair in cancer biology. [1] He was elected to the National Academy of Sciences in 2019. [2] Raulet is also the co-founder of Dragonfly Therapeutics, [3] a company that seeks to use natural killer cells for cancer immunotherapy.
Raulet was born in Buffalo, New York. [2] He graduated from the University of Michigan with a bachelor's degree in microbiology. [4] He then received his Ph.D. in biology from the Massachusetts Institute of Technology. [4] Raulet went on to conduct postdoctoral research in the Department of Pathology at the Perelman School of Medicine at the University of Pennsylvania. [2]
Raulet joined the faculty at MIT in 1983, and moved to the Department of Molecular and Cell Biology at the University of California, Berkeley in 1991. [2]
David H. Raulet is an immunologist who specializes in studying the role of natural killer cells. He is a professor in the Department of Molecular and Cell Biology at the University of California, Berkeley where he also holds the Esther and Wendy Schekman Chair in cancer biology. [1] He was elected to the National Academy of Sciences in 2019. [2] Raulet is also the co-founder of Dragonfly Therapeutics, [3] a company that seeks to use natural killer cells for cancer immunotherapy.
Raulet was born in Buffalo, New York. [2] He graduated from the University of Michigan with a bachelor's degree in microbiology. [4] He then received his Ph.D. in biology from the Massachusetts Institute of Technology. [4] Raulet went on to conduct postdoctoral research in the Department of Pathology at the Perelman School of Medicine at the University of Pennsylvania. [2]
Raulet joined the faculty at MIT in 1983, and moved to the Department of Molecular and Cell Biology at the University of California, Berkeley in 1991. [2]